Pharma & Biotech

The German biotech firm BioNTech finds itself at a pivotal moment. As the company navigates the final stages of its...

The market delivered a harsh verdict on InnoCan Pharma's latest financial performance, sending the Canadian pharmaceutical technology company's stock sharply...

Investors in Ocugen are witnessing a potential turning point following a period of significant volatility. The catalyst for renewed optimism...

Tango Therapeutics is capturing market attention with a powerful upward move, propelled by significant clinical developments and a landmark achievement...

Assembly Biosciences shares are navigating a pivotal moment in their trading pattern. The biotechnology firm entered a crucial consolidation phase...

After months of disappointing performance that saw its value cut in half since the start of the year, Redcare Pharmacy...

As U.S. markets operated on a shortened post-Thanksgiving schedule, research departments remained active, with Viking Therapeutics generating significant analyst enthusiasm....

Novo Nordisk's stock has entered a dramatic downturn, shedding more than half its value since the start of the year...

The independent existence of CureVac as a publicly traded company is drawing to a close. Following decisive shareholder approval, the...

A severe clinical setback has struck Intellia Therapeutics, sending its stock value tumbling after the U.S. Food and Drug Administration...